Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan.
Haraguchi M, Yamamoto H, Watanabe O, Sakoh T, Ishida K, Ogura S, Katoh-Morishima M, Taya Y, Nishida A, Kaji D, Takagi S, Yamamoto G, Uchida N, Araoka H. Haraguchi M, et al. Among authors: watanabe o. Bone Marrow Transplant. 2023 Sep;58(9):1051-1053. doi: 10.1038/s41409-023-02019-y. Epub 2023 Jun 17. Bone Marrow Transplant. 2023. PMID: 37330600 Free PMC article. No abstract available.
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia.
Kato K, Takagi S, Takano H, Tsunoda S, Watanabe O, Yamaguchi K, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Koike Y, Makino S, Wake A, Taniguchi S, Uchida N. Kato K, et al. Among authors: watanabe o. Int J Hematol. 2024 Feb;119(2):205-209. doi: 10.1007/s12185-023-03691-y. Epub 2024 Jan 18. Int J Hematol. 2024. PMID: 38236369
Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation.
Tsumita K, Takagi S, Asano-Mori Y, Watanabe O, Shindo M, Yamaguchi K, Yuasa M, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Araoka H, Yamamoto G, Makino S, Wake A, Uchida N, Taniguchi S, Koike Y. Tsumita K, et al. Among authors: watanabe o. Int J Hematol. 2024 May;119(5):573-582. doi: 10.1007/s12185-024-03727-x. Epub 2024 Feb 26. Int J Hematol. 2024. PMID: 38407785
Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1.
Osada M, Yamamoto H, Watanabe O, Yamaguchi K, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Makino S, Asano-Mori Y, Yamamoto G, Taniguchi S, Wake A, Uchida N. Osada M, et al. Among authors: watanabe o. Transplant Cell Ther. 2024 Apr 17:S2666-6367(24)00350-6. doi: 10.1016/j.jtct.2024.04.011. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38641011
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
Sato T, Nagai M, Watanabe O, Misu T, Takenouchi N, Ohkubo R, Ishihara S, Tsuboi Y, Katsuno M, Nakagawa M, Matsushita T, Aso Y, Matsuura E, Tokashiki T, Mukaino A, Adachi H, Nakanishi K, Yamaguchi Y, Yamaguchi S, Yamano Y. Sato T, et al. Among authors: watanabe o. J Neurol. 2024 Mar 2. doi: 10.1007/s00415-024-12239-x. Online ahead of print. J Neurol. 2024. PMID: 38430272
449 results